CHRONIC MYELOMONOCYTIC LEUKEMIA
Clinical trials for CHRONIC MYELOMONOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new CHRONIC MYELOMONOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for CHRONIC MYELOMONOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare blood cancers? immune therapy trial seeks to tame disease
Disease control Not yet recruitingThis study is testing a long-acting immune therapy drug called ropeginterferon alfa-2b for adults with rare, overlapping blood cancers like chronic myelomonocytic leukemia (CMML). The main goals are to find a safe and effective dose and to see if the drug can control the disease …
Matched conditions: CHRONIC MYELOMONOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New drug combo tested for Tough-to-Treat blood cancers
Disease control Not yet recruitingThis early-stage study is testing whether adding an oral drug called momelotinib to a standard injected therapy (azacitidine) is safe and effective for people with certain rare, overlapping blood cancers. The goal is to better control the disease, reduce symptoms like an enlarged…
Matched conditions: CHRONIC MYELOMONOCYTIC LEUKEMIA
Phase: EARLY_PHASE1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC